Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Ischemic colitis complicated by Clostridioides difficile infection treated with fecal microbiota transplantation

  • Seok Hyung Kang (Division of Gastroenterology, International St. Mary's Hospital, Catholic Kwandong University, College of Medicine) ;
  • Tae-Geun Gweon (Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Hyunjung Hwang (Division of Gastroenterology, International St. Mary's Hospital, Catholic Kwandong University, College of Medicine) ;
  • Myong Ki Baeg (Division of Gastroenterology, International St. Mary's Hospital, Catholic Kwandong University, College of Medicine)
  • Received : 2021.07.05
  • Accepted : 2021.08.28
  • Published : 2023.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Ischemic colitis is an inflammatory condition of the colon that results from insufficient blood supply commonly caused by enterocolitis, vessel occlusion, or shock. In contrast, pseudomembranous colitis is a clinical manifestation of Clostridioides difficile infection (CDI). Ischemic colitis caused by CDI has rarely been reported. Fecal microbiota transplantation (FMT) is an efficient treatment for refractory or fulminant CDI, and the indications for its use have recently expanded. However, performing FMT in patients with ischemic colitis is challenging because of the risk of perforation. Here, we have presented a case of ischemic colitis caused by CDI that was successfully treated with FMT via sigmoidoscopy.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (grant number: NRF-2021R1G1A1094049).

References

  1. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455. 
  2. Trotter JM, Hunt L, Peter MB. Ischaemic colitis. BMJ 2016;355:i6600. 
  3. Moulis H, Vender RJ. Antibiotic-associated hemorrhagic colitis. J Clin Gastroenterol 1994;18:227-231. 
  4. Kendrick JB, Risbano M, Groshong SD, et al. A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7. Clin Infect Dis 2007;45:217-219. 
  5. Moore T, Rodriguez A, Bakken JS. Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin Infect Dis 2014;58:541-545. 
  6. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014;109:1065-1071. 
  7. Gweon TG, Na SY. Next generation fecal microbiota transplantation. Clin Endosc 2021;54:152-156. 
  8. Jaber MR, Olafsson S, Fung WL, et al. Clinical review of the management of fulminant clostridium difficile infection. Am J Gastroenterol 2008;103:3195-3203. 
  9. Fischer M, Sipe BW, Rogers NA, et al. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 2015;42:470-476. 
  10. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002. 
  11. Gweon TG, Kim J, Lim CH, et al. Fecal microbiota transplantation using upper gastrointestinal tract for the treatment of refractory or severe complicated Clostridium difficile infection in elderly patients in poor medical condition: the first study in an Asian country. Gastroenterol Res Pract 2016;2016:2687605. 
  12. Gweon TG, Lee KJ, Kang DH, et al. A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation. Gut Liver 2015;9:247-250. 
  13. Martin JSH, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol 2016;13:206-216. 
  14. Fischer M, Kao D, Mehta SR, et al. Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium difficile infection: a multicenter study. Am J Gastroenterol 2016;111:1024-1031.